HEADER HYDROLASE 01-JUN-22 7XYD TITLE CRYSTAL STRUCTURE OF TMPRSS2 IN COMPLEX WITH NAFAMOSTAT COMPND MOL_ID: 1; COMPND 2 MOLECULE: TRANSMEMBRANE PROTEASE SERINE 2 CATALYTIC CHAIN; COMPND 3 CHAIN: A, B; COMPND 4 ENGINEERED: YES; COMPND 5 MUTATION: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: TRANSMEMBRANE PROTEASE SERINE 2 CATALYTIC CHAIN; COMPND 8 CHAIN: C, D; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: TMPRSS2, PRSS10; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_COMMON: HUMAN; SOURCE 11 ORGANISM_TAXID: 9606; SOURCE 12 GENE: TMPRSS2, PRSS10; SOURCE 13 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS INHIBITOR, COMPLEX, HOST, ANTIVIRAL, ANTIVIRAL PROTEIN, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR H.WANG,X.LIU,Y.DUAN,X.LIU,L.SUN,H.YANG REVDAT 2 19-JUN-24 7XYD 1 JRNL REVDAT 1 06-DEC-23 7XYD 0 JRNL AUTH H.WANG,Q.YANG,X.LIU,Z.XU,M.SHAO,D.LI,Y.DUAN,J.TANG,X.YU, JRNL AUTH 2 Y.ZHANG,A.HAO,Y.WANG,J.CHEN,C.ZHU,L.GUDDAT,H.CHEN,L.ZHANG, JRNL AUTH 3 X.CHEN,B.JIANG,L.SUN,Z.RAO,H.YANG JRNL TITL STRUCTURE-BASED DISCOVERY OF DUAL PATHWAY INHIBITORS FOR JRNL TITL 2 SARS-COV-2 ENTRY. JRNL REF NAT COMMUN V. 14 7574 2023 JRNL REFN ESSN 2041-1723 JRNL PMID 37990007 JRNL DOI 10.1038/S41467-023-42527-5 REMARK 2 REMARK 2 RESOLUTION. 2.58 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.18.2_3874 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.58 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 39.81 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.5 REMARK 3 NUMBER OF REFLECTIONS : 25657 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.214 REMARK 3 R VALUE (WORKING SET) : 0.211 REMARK 3 FREE R VALUE : 0.248 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 7.810 REMARK 3 FREE R VALUE TEST SET COUNT : 2004 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 39.8100 - 6.2200 0.97 1703 147 0.1923 0.1951 REMARK 3 2 6.2100 - 4.9400 0.96 1669 133 0.1944 0.2001 REMARK 3 3 4.9300 - 4.3100 0.99 1736 142 0.1663 0.1850 REMARK 3 4 4.3100 - 3.9200 0.97 1651 141 0.1733 0.2206 REMARK 3 5 3.9200 - 3.6400 0.99 1682 143 0.1915 0.2190 REMARK 3 6 3.6400 - 3.4200 1.00 1715 147 0.2089 0.2521 REMARK 3 7 3.4200 - 3.2500 1.00 1696 146 0.2212 0.2616 REMARK 3 8 3.2500 - 3.1100 0.99 1684 153 0.2257 0.3267 REMARK 3 9 3.1100 - 2.9900 0.97 1685 131 0.2517 0.2671 REMARK 3 10 2.9900 - 2.8900 1.00 1683 146 0.2648 0.3246 REMARK 3 11 2.8900 - 2.8000 1.00 1707 150 0.2626 0.3184 REMARK 3 12 2.8000 - 2.7200 0.99 1687 141 0.2765 0.3270 REMARK 3 13 2.7200 - 2.6500 0.99 1727 132 0.2693 0.3195 REMARK 3 14 2.6500 - 2.5800 0.98 1628 152 0.3143 0.4036 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.10 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.380 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 25.640 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.006 5829 REMARK 3 ANGLE : 0.822 7939 REMARK 3 CHIRALITY : 0.056 844 REMARK 3 PLANARITY : 0.010 1027 REMARK 3 DIHEDRAL : 16.499 2019 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7XYD COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 02-NOV-22. REMARK 100 THE DEPOSITION ID IS D_1300028881. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 16-DEC-21 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 4.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRF REMARK 200 BEAMLINE : BL19U1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97930 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS 2020-12-02 REMARK 200 DATA SCALING SOFTWARE : XDS 2020-12-02 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 25667 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.580 REMARK 200 RESOLUTION RANGE LOW (A) : 39.810 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.5 REMARK 200 DATA REDUNDANCY : 5.290 REMARK 200 R MERGE (I) : 0.17100 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 8.1100 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.58 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.74 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.84500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX 1.18.2_3874 REMARK 200 STARTING MODEL: MODEL PREDICTED BY ALPHAFOLD REMARK 200 REMARK 200 REMARK: PLATE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.90 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.36 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M ACETIC ACID/SODIUM ACETATE, PH REMARK 280 4.0, 20% W/V PEG 4000, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 46.60150 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2840 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 16090 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -8.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2720 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15960 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -7.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 109 REMARK 465 GLY A 110 REMARK 465 SER A 111 REMARK 465 LYS A 112 REMARK 465 CYS A 113 REMARK 465 SER A 114 REMARK 465 ASN A 115 REMARK 465 SER A 116 REMARK 465 SER A 123 REMARK 465 GLY A 124 REMARK 465 THR A 125 REMARK 465 ASN A 218 REMARK 465 VAL A 219 REMARK 465 ASP A 251 REMARK 465 ASP A 252 REMARK 465 ASP A 253 REMARK 465 LYS A 254 REMARK 465 HIS C 498 REMARK 465 HIS C 499 REMARK 465 HIS C 500 REMARK 465 HIS C 501 REMARK 465 HIS C 502 REMARK 465 HIS C 503 REMARK 465 HIS C 504 REMARK 465 MET B 109 REMARK 465 GLY B 110 REMARK 465 SER B 111 REMARK 465 LYS B 112 REMARK 465 SER B 122 REMARK 465 SER B 123 REMARK 465 GLY B 124 REMARK 465 ASP B 202 REMARK 465 ASP B 203 REMARK 465 SER B 204 REMARK 465 GLY B 205 REMARK 465 SER B 206 REMARK 465 THR B 207 REMARK 465 ALA B 216 REMARK 465 GLY B 217 REMARK 465 ASN B 249 REMARK 465 ASP B 250 REMARK 465 ASP B 251 REMARK 465 ASP B 252 REMARK 465 ASP B 253 REMARK 465 LYS B 254 REMARK 465 VAL D 495 REMARK 465 GLU D 496 REMARK 465 HIS D 497 REMARK 465 HIS D 498 REMARK 465 HIS D 499 REMARK 465 HIS D 500 REMARK 465 HIS D 501 REMARK 465 HIS D 502 REMARK 465 HIS D 503 REMARK 465 HIS D 504 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ILE A 118 CG1 CG2 CD1 REMARK 470 GLU A 119 CG CD OE1 OE2 REMARK 470 SER A 122 OG REMARK 470 CYS A 126 SG REMARK 470 LYS A 166 CG CD CE NZ REMARK 470 LYS A 224 CG CD CE NZ REMARK 470 LYS C 330 CG CD CE NZ REMARK 470 LYS C 340 CG CD CE NZ REMARK 470 LYS C 353 CG CD CE NZ REMARK 470 LYS C 392 CG CD CE NZ REMARK 470 GLN C 408 CG CD OE1 NE2 REMARK 470 ARG C 413 CG CD NE CZ NH1 NH2 REMARK 470 LEU C 430 CG CD1 CD2 REMARK 470 GLN C 431 CG CD OE1 NE2 REMARK 470 ILE B 157 CG1 CG2 CD1 REMARK 470 GLN B 198 CG CD OE1 NE2 REMARK 470 ILE B 200 CG1 CG2 CD1 REMARK 470 LYS B 223 CG CD CE NZ REMARK 470 LEU B 225 CG CD1 CD2 REMARK 470 ASP B 229 CG OD1 OD2 REMARK 470 LYS B 234 CG CD CE NZ REMARK 470 LEU B 248 CG CD1 CD2 REMARK 470 GLU D 260 CG CD OE1 OE2 REMARK 470 LYS D 340 CG CD CE NZ REMARK 470 LYS D 390 CG CD CE NZ REMARK 470 GLU D 406 CG CD OE1 OE2 REMARK 470 GLN D 438 CG CD OE1 NE2 REMARK 470 GLU D 493 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 191 -128.44 53.11 REMARK 500 THR A 214 -20.88 82.65 REMARK 500 ASN A 247 -158.99 -111.02 REMARK 500 ASN C 344 35.03 71.79 REMARK 500 VAL C 415 -81.04 -109.57 REMARK 500 ASN C 433 -16.16 71.83 REMARK 500 SER B 116 23.85 48.43 REMARK 500 CYS B 120 48.77 -82.56 REMARK 500 ARG B 165 -15.35 76.26 REMARK 500 LYS B 191 -127.48 53.74 REMARK 500 GLN B 198 -52.92 -120.21 REMARK 500 VAL D 415 -72.58 -125.75 REMARK 500 ASN D 433 -26.53 78.97 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA A 302 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASN A 131 O REMARK 620 2 ASP A 134 OD1 102.4 REMARK 620 3 VAL A 136 O 167.4 80.7 REMARK 620 4 ASP A 144 OD2 97.3 157.5 82.3 REMARK 620 5 GLU A 145 OE2 111.7 75.5 80.8 87.3 REMARK 620 N 1 2 3 4 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA B 302 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASN B 131 O REMARK 620 2 ASP B 134 OD1 74.2 REMARK 620 3 VAL B 136 O 156.8 90.5 REMARK 620 4 ASP B 144 OD2 101.1 173.4 95.3 REMARK 620 5 GLU B 145 OE2 108.1 68.2 81.3 109.6 REMARK 620 N 1 2 3 4 REMARK 999 REMARK 999 SEQUENCE REMARK 999 CHAINS A AND C, AS WELL AS B AND D, WERE MANIPULATED AS ONE SINGLE REMARK 999 PEPTIDE, BUT AUTO-CLEAVED AT RESIDUE 256 DURING ZYMOGEN ACTIVATION. DBREF 7XYD A 109 254 UNP O15393 TMPS2_HUMAN 109 254 DBREF 7XYD C 256 492 UNP O15393 TMPS2_HUMAN 256 492 DBREF 7XYD B 109 254 UNP O15393 TMPS2_HUMAN 109 254 DBREF 7XYD D 256 492 UNP O15393 TMPS2_HUMAN 256 492 SEQADV 7XYD ASP A 250 UNP O15393 SER 250 ENGINEERED MUTATION SEQADV 7XYD ASP A 251 UNP O15393 SER 251 ENGINEERED MUTATION SEQADV 7XYD ASP A 252 UNP O15393 ARG 252 ENGINEERED MUTATION SEQADV 7XYD ASP A 253 UNP O15393 GLN 253 ENGINEERED MUTATION SEQADV 7XYD LYS A 254 UNP O15393 SER 254 ENGINEERED MUTATION SEQADV 7XYD GLU C 493 UNP O15393 EXPRESSION TAG SEQADV 7XYD PHE C 494 UNP O15393 EXPRESSION TAG SEQADV 7XYD VAL C 495 UNP O15393 EXPRESSION TAG SEQADV 7XYD GLU C 496 UNP O15393 EXPRESSION TAG SEQADV 7XYD HIS C 497 UNP O15393 EXPRESSION TAG SEQADV 7XYD HIS C 498 UNP O15393 EXPRESSION TAG SEQADV 7XYD HIS C 499 UNP O15393 EXPRESSION TAG SEQADV 7XYD HIS C 500 UNP O15393 EXPRESSION TAG SEQADV 7XYD HIS C 501 UNP O15393 EXPRESSION TAG SEQADV 7XYD HIS C 502 UNP O15393 EXPRESSION TAG SEQADV 7XYD HIS C 503 UNP O15393 EXPRESSION TAG SEQADV 7XYD HIS C 504 UNP O15393 EXPRESSION TAG SEQADV 7XYD ASP B 250 UNP O15393 SER 250 ENGINEERED MUTATION SEQADV 7XYD ASP B 251 UNP O15393 SER 251 ENGINEERED MUTATION SEQADV 7XYD ASP B 252 UNP O15393 ARG 252 ENGINEERED MUTATION SEQADV 7XYD ASP B 253 UNP O15393 GLN 253 ENGINEERED MUTATION SEQADV 7XYD LYS B 254 UNP O15393 SER 254 ENGINEERED MUTATION SEQADV 7XYD GLU D 493 UNP O15393 EXPRESSION TAG SEQADV 7XYD PHE D 494 UNP O15393 EXPRESSION TAG SEQADV 7XYD VAL D 495 UNP O15393 EXPRESSION TAG SEQADV 7XYD GLU D 496 UNP O15393 EXPRESSION TAG SEQADV 7XYD HIS D 497 UNP O15393 EXPRESSION TAG SEQADV 7XYD HIS D 498 UNP O15393 EXPRESSION TAG SEQADV 7XYD HIS D 499 UNP O15393 EXPRESSION TAG SEQADV 7XYD HIS D 500 UNP O15393 EXPRESSION TAG SEQADV 7XYD HIS D 501 UNP O15393 EXPRESSION TAG SEQADV 7XYD HIS D 502 UNP O15393 EXPRESSION TAG SEQADV 7XYD HIS D 503 UNP O15393 EXPRESSION TAG SEQADV 7XYD HIS D 504 UNP O15393 EXPRESSION TAG SEQRES 1 A 146 MET GLY SER LYS CYS SER ASN SER GLY ILE GLU CYS ASP SEQRES 2 A 146 SER SER GLY THR CYS ILE ASN PRO SER ASN TRP CYS ASP SEQRES 3 A 146 GLY VAL SER HIS CYS PRO GLY GLY GLU ASP GLU ASN ARG SEQRES 4 A 146 CYS VAL ARG LEU TYR GLY PRO ASN PHE ILE LEU GLN VAL SEQRES 5 A 146 TYR SER SER GLN ARG LYS SER TRP HIS PRO VAL CYS GLN SEQRES 6 A 146 ASP ASP TRP ASN GLU ASN TYR GLY ARG ALA ALA CYS ARG SEQRES 7 A 146 ASP MET GLY TYR LYS ASN ASN PHE TYR SER SER GLN GLY SEQRES 8 A 146 ILE VAL ASP ASP SER GLY SER THR SER PHE MET LYS LEU SEQRES 9 A 146 ASN THR SER ALA GLY ASN VAL ASP ILE TYR LYS LYS LEU SEQRES 10 A 146 TYR HIS SER ASP ALA CYS SER SER LYS ALA VAL VAL SER SEQRES 11 A 146 LEU ARG CYS ILE ALA CYS GLY VAL ASN LEU ASN ASP ASP SEQRES 12 A 146 ASP ASP LYS SEQRES 1 C 249 ILE VAL GLY GLY GLU SER ALA LEU PRO GLY ALA TRP PRO SEQRES 2 C 249 TRP GLN VAL SER LEU HIS VAL GLN ASN VAL HIS VAL CYS SEQRES 3 C 249 GLY GLY SER ILE ILE THR PRO GLU TRP ILE VAL THR ALA SEQRES 4 C 249 ALA HIS CYS VAL GLU LYS PRO LEU ASN ASN PRO TRP HIS SEQRES 5 C 249 TRP THR ALA PHE ALA GLY ILE LEU ARG GLN SER PHE MET SEQRES 6 C 249 PHE TYR GLY ALA GLY TYR GLN VAL GLU LYS VAL ILE SER SEQRES 7 C 249 HIS PRO ASN TYR ASP SER LYS THR LYS ASN ASN ASP ILE SEQRES 8 C 249 ALA LEU MET LYS LEU GLN LYS PRO LEU THR PHE ASN ASP SEQRES 9 C 249 LEU VAL LYS PRO VAL CYS LEU PRO ASN PRO GLY MET MET SEQRES 10 C 249 LEU GLN PRO GLU GLN LEU CYS TRP ILE SER GLY TRP GLY SEQRES 11 C 249 ALA THR GLU GLU LYS GLY LYS THR SER GLU VAL LEU ASN SEQRES 12 C 249 ALA ALA LYS VAL LEU LEU ILE GLU THR GLN ARG CYS ASN SEQRES 13 C 249 SER ARG TYR VAL TYR ASP ASN LEU ILE THR PRO ALA MET SEQRES 14 C 249 ILE CYS ALA GLY PHE LEU GLN GLY ASN VAL ASP SER CYS SEQRES 15 C 249 GLN GLY ASP SER GLY GLY PRO LEU VAL THR SER LYS ASN SEQRES 16 C 249 ASN ILE TRP TRP LEU ILE GLY ASP THR SER TRP GLY SER SEQRES 17 C 249 GLY CYS ALA LYS ALA TYR ARG PRO GLY VAL TYR GLY ASN SEQRES 18 C 249 VAL MET VAL PHE THR ASP TRP ILE TYR ARG GLN MET ARG SEQRES 19 C 249 ALA ASP GLY GLU PHE VAL GLU HIS HIS HIS HIS HIS HIS SEQRES 20 C 249 HIS HIS SEQRES 1 B 146 MET GLY SER LYS CYS SER ASN SER GLY ILE GLU CYS ASP SEQRES 2 B 146 SER SER GLY THR CYS ILE ASN PRO SER ASN TRP CYS ASP SEQRES 3 B 146 GLY VAL SER HIS CYS PRO GLY GLY GLU ASP GLU ASN ARG SEQRES 4 B 146 CYS VAL ARG LEU TYR GLY PRO ASN PHE ILE LEU GLN VAL SEQRES 5 B 146 TYR SER SER GLN ARG LYS SER TRP HIS PRO VAL CYS GLN SEQRES 6 B 146 ASP ASP TRP ASN GLU ASN TYR GLY ARG ALA ALA CYS ARG SEQRES 7 B 146 ASP MET GLY TYR LYS ASN ASN PHE TYR SER SER GLN GLY SEQRES 8 B 146 ILE VAL ASP ASP SER GLY SER THR SER PHE MET LYS LEU SEQRES 9 B 146 ASN THR SER ALA GLY ASN VAL ASP ILE TYR LYS LYS LEU SEQRES 10 B 146 TYR HIS SER ASP ALA CYS SER SER LYS ALA VAL VAL SER SEQRES 11 B 146 LEU ARG CYS ILE ALA CYS GLY VAL ASN LEU ASN ASP ASP SEQRES 12 B 146 ASP ASP LYS SEQRES 1 D 249 ILE VAL GLY GLY GLU SER ALA LEU PRO GLY ALA TRP PRO SEQRES 2 D 249 TRP GLN VAL SER LEU HIS VAL GLN ASN VAL HIS VAL CYS SEQRES 3 D 249 GLY GLY SER ILE ILE THR PRO GLU TRP ILE VAL THR ALA SEQRES 4 D 249 ALA HIS CYS VAL GLU LYS PRO LEU ASN ASN PRO TRP HIS SEQRES 5 D 249 TRP THR ALA PHE ALA GLY ILE LEU ARG GLN SER PHE MET SEQRES 6 D 249 PHE TYR GLY ALA GLY TYR GLN VAL GLU LYS VAL ILE SER SEQRES 7 D 249 HIS PRO ASN TYR ASP SER LYS THR LYS ASN ASN ASP ILE SEQRES 8 D 249 ALA LEU MET LYS LEU GLN LYS PRO LEU THR PHE ASN ASP SEQRES 9 D 249 LEU VAL LYS PRO VAL CYS LEU PRO ASN PRO GLY MET MET SEQRES 10 D 249 LEU GLN PRO GLU GLN LEU CYS TRP ILE SER GLY TRP GLY SEQRES 11 D 249 ALA THR GLU GLU LYS GLY LYS THR SER GLU VAL LEU ASN SEQRES 12 D 249 ALA ALA LYS VAL LEU LEU ILE GLU THR GLN ARG CYS ASN SEQRES 13 D 249 SER ARG TYR VAL TYR ASP ASN LEU ILE THR PRO ALA MET SEQRES 14 D 249 ILE CYS ALA GLY PHE LEU GLN GLY ASN VAL ASP SER CYS SEQRES 15 D 249 GLN GLY ASP SER GLY GLY PRO LEU VAL THR SER LYS ASN SEQRES 16 D 249 ASN ILE TRP TRP LEU ILE GLY ASP THR SER TRP GLY SER SEQRES 17 D 249 GLY CYS ALA LYS ALA TYR ARG PRO GLY VAL TYR GLY ASN SEQRES 18 D 249 VAL MET VAL PHE THR ASP TRP ILE TYR ARG GLN MET ARG SEQRES 19 D 249 ALA ASP GLY GLU PHE VAL GLU HIS HIS HIS HIS HIS HIS SEQRES 20 D 249 HIS HIS HET NAG A 301 14 HET CA A 302 1 HET GBS C 601 12 HET NAG B 301 14 HET CA B 302 1 HET GBS D 601 12 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM CA CALCIUM ION HETNAM GBS 4-CARBAMIMIDAMIDOBENZOIC ACID HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN GBS NAFAMOSTAT, BOUND FORM FORMUL 5 NAG 2(C8 H15 N O6) FORMUL 6 CA 2(CA 2+) FORMUL 7 GBS 2(C8 H9 N3 O2) FORMUL 11 HOH *153(H2 O) HELIX 1 AA1 ASN A 128 TRP A 132 5 5 HELIX 2 AA2 ASN A 177 MET A 188 1 12 HELIX 3 AA3 ALA C 294 GLU C 299 5 6 HELIX 4 AA4 ASN C 304 HIS C 307 5 4 HELIX 5 AA5 ARG C 316 MET C 320 5 5 HELIX 6 AA6 GLU C 406 ASN C 411 1 6 HELIX 7 AA7 VAL C 477 VAL C 495 1 19 HELIX 8 AA8 ASN B 128 TRP B 132 5 5 HELIX 9 AA9 SER B 163 LYS B 166 5 4 HELIX 10 AB1 ASN B 177 MET B 188 1 12 HELIX 11 AB2 ASP B 220 LYS B 223 5 4 HELIX 12 AB3 ALA D 294 GLU D 299 5 6 HELIX 13 AB4 ASN D 304 HIS D 307 5 4 HELIX 14 AB5 ARG D 316 MET D 320 5 5 HELIX 15 AB6 GLU D 406 ASN D 411 1 6 HELIX 16 AB7 VAL D 477 GLU D 493 1 17 SHEET 1 AA1 3 VAL A 149 TYR A 152 0 SHEET 2 AA1 3 ILE A 157 SER A 162 -1 O ILE A 157 N TYR A 152 SHEET 3 AA1 3 SER A 167 PRO A 170 -1 O SER A 167 N SER A 162 SHEET 1 AA2 2 SER A 196 ILE A 200 0 SHEET 2 AA2 2 VAL A 236 ARG A 240 -1 O VAL A 236 N ILE A 200 SHEET 1 AA3 2 PHE A 209 LEU A 212 0 SHEET 2 AA3 2 LEU A 225 SER A 228 -1 O SER A 228 N PHE A 209 SHEET 1 AA4 8 GLU C 260 SER C 261 0 SHEET 2 AA4 8 ASN C 398 ILE C 405 -1 O ALA C 399 N GLU C 260 SHEET 3 AA4 8 MET C 424 GLY C 428 -1 O CYS C 426 N ILE C 405 SHEET 4 AA4 8 GLY C 472 ASN C 476 -1 O TYR C 474 N ILE C 425 SHEET 5 AA4 8 ILE C 452 TRP C 461 -1 N ASP C 458 O GLY C 475 SHEET 6 AA4 8 PRO C 444 LYS C 449 -1 N THR C 447 O TRP C 454 SHEET 7 AA4 8 LEU C 378 GLY C 383 -1 N TRP C 380 O VAL C 446 SHEET 8 AA4 8 ASN C 398 ILE C 405 -1 O VAL C 402 N CYS C 379 SHEET 1 AA5 7 GLN C 270 VAL C 275 0 SHEET 2 AA5 7 VAL C 278 THR C 287 -1 O VAL C 280 N LEU C 273 SHEET 3 AA5 7 TRP C 290 THR C 293 -1 O VAL C 292 N SER C 284 SHEET 4 AA5 7 ALA C 347 LEU C 351 -1 O ALA C 347 N THR C 293 SHEET 5 AA5 7 TYR C 326 SER C 333 -1 N GLU C 329 O LYS C 350 SHEET 6 AA5 7 THR C 309 ALA C 312 -1 N ALA C 310 O TYR C 326 SHEET 7 AA5 7 GLN C 270 VAL C 275 -1 N HIS C 274 O THR C 309 SHEET 1 AA6 2 ILE B 118 GLU B 119 0 SHEET 2 AA6 2 CYS B 126 ILE B 127 -1 O ILE B 127 N ILE B 118 SHEET 1 AA7 3 VAL B 149 TYR B 152 0 SHEET 2 AA7 3 ILE B 157 SER B 162 -1 O GLN B 159 N ARG B 150 SHEET 3 AA7 3 SER B 167 PRO B 170 -1 O SER B 167 N SER B 162 SHEET 1 AA8 2 SER B 196 SER B 197 0 SHEET 2 AA8 2 LEU B 239 ARG B 240 -1 O ARG B 240 N SER B 196 SHEET 1 AA9 2 PHE B 209 LEU B 212 0 SHEET 2 AA9 2 LEU B 225 SER B 228 -1 O TYR B 226 N LYS B 211 SHEET 1 AB1 8 GLU D 260 SER D 261 0 SHEET 2 AB1 8 ASN D 398 ILE D 405 -1 O ALA D 399 N GLU D 260 SHEET 3 AB1 8 MET D 424 GLY D 428 -1 O CYS D 426 N ILE D 405 SHEET 4 AB1 8 GLY D 472 ASN D 476 -1 O TYR D 474 N ILE D 425 SHEET 5 AB1 8 ILE D 452 TRP D 461 -1 N TRP D 461 O VAL D 473 SHEET 6 AB1 8 PRO D 444 LYS D 449 -1 N LEU D 445 O GLY D 457 SHEET 7 AB1 8 LEU D 378 GLY D 383 -1 N TRP D 380 O VAL D 446 SHEET 8 AB1 8 ASN D 398 ILE D 405 -1 O VAL D 402 N CYS D 379 SHEET 1 AB2 7 GLN D 270 VAL D 275 0 SHEET 2 AB2 7 VAL D 278 ILE D 285 -1 O CYS D 281 N LEU D 273 SHEET 3 AB2 7 TRP D 290 THR D 293 -1 O VAL D 292 N SER D 284 SHEET 4 AB2 7 ALA D 347 LEU D 351 -1 O ALA D 347 N THR D 293 SHEET 5 AB2 7 TYR D 326 SER D 333 -1 N LYS D 330 O LYS D 350 SHEET 6 AB2 7 THR D 309 ALA D 312 -1 N ALA D 310 O TYR D 326 SHEET 7 AB2 7 GLN D 270 VAL D 275 -1 N HIS D 274 O THR D 309 SSBOND 1 CYS A 120 CYS A 139 1555 1555 2.04 SSBOND 2 CYS A 133 CYS A 148 1555 1555 2.03 SSBOND 3 CYS A 172 CYS A 231 1555 1555 2.04 SSBOND 4 CYS A 185 CYS A 241 1555 1555 2.03 SSBOND 5 CYS A 244 CYS C 365 1555 1555 2.03 SSBOND 6 CYS C 281 CYS C 297 1555 1555 2.03 SSBOND 7 CYS C 410 CYS C 426 1555 1555 2.03 SSBOND 8 CYS C 437 CYS C 465 1555 1555 2.03 SSBOND 9 CYS B 113 CYS B 126 1555 1555 2.03 SSBOND 10 CYS B 120 CYS B 139 1555 1555 2.03 SSBOND 11 CYS B 133 CYS B 148 1555 1555 2.03 SSBOND 12 CYS B 172 CYS B 231 1555 1555 2.03 SSBOND 13 CYS B 185 CYS B 241 1555 1555 2.03 SSBOND 14 CYS B 244 CYS D 365 1555 1555 2.03 SSBOND 15 CYS D 281 CYS D 297 1555 1555 2.05 SSBOND 16 CYS D 410 CYS D 426 1555 1555 2.03 SSBOND 17 CYS D 437 CYS D 465 1555 1555 2.03 LINK ND2 ASN A 213 C1 NAG A 301 1555 1555 1.44 LINK OG SER C 441 C6 GBS C 601 1555 1555 1.47 LINK ND2 ASN B 213 C1 NAG B 301 1555 1555 1.45 LINK OG SER D 441 C6 GBS D 601 1555 1555 1.47 LINK O ASN A 131 CA CA A 302 1555 1555 2.22 LINK OD1 ASP A 134 CA CA A 302 1555 1555 2.37 LINK O VAL A 136 CA CA A 302 1555 1555 2.48 LINK OD2 ASP A 144 CA CA A 302 1555 1555 2.42 LINK OE2 GLU A 145 CA CA A 302 1555 1555 2.31 LINK O ASN B 131 CA CA B 302 1555 1555 2.13 LINK OD1 ASP B 134 CA CA B 302 1555 1555 2.30 LINK O VAL B 136 CA CA B 302 1555 1555 2.22 LINK OD2 ASP B 144 CA CA B 302 1555 1555 2.48 LINK OE2 GLU B 145 CA CA B 302 1555 1555 2.78 CISPEP 1 LYS C 300 PRO C 301 0 8.56 CISPEP 2 LYS D 300 PRO D 301 0 4.16 CRYST1 49.140 93.203 93.130 90.00 100.60 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020350 0.000000 0.003808 0.00000 SCALE2 0.000000 0.010729 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010924 0.00000